Naproxen Cf

Naproxen, the active ingredient in Naproxen Cf, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is employed to relieve mild to moderate pain, reduce inflammation associated with conditions such as arthritis, and lower fever in adult patients.

GNH USA supplies Naproxen Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution to meet the needs of healthcare providers.

Naproxen is an NSAID that reduces inflammation and pain by reversibly inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin production.

- Mild to moderate pain: Provides analgesic relief for headaches, dental pain, musculoskeletal aches, and other acute pain conditions. - Inflammatory arthritis: Decreases joint swelling and stiffness in osteoarthritis and rheumatoid arthritis. - Dysmenorrhea: Alleviates menstrual cramps and associated pelvic discomfort. - Fever: Lowers elevated body temperature in febrile states. - Post‑operative pain: Helps control pain after minor surgical procedures.

Adverse reactions may occur with naproxen use and are categorized by frequency.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Mild skin rash or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment or acute kidney injury. - Cardiovascular events such as myocardial infarction or stroke. - Severe skin reactions including Stevens‑Johnson syndrome. - Hepatic dysfunction with elevated liver enzymes. - Anaphylaxis or severe hypersensitivity reactions.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

- Assess gastrointestinal risk: use the lowest effective dose and consider gastro‑protective agents in high‑risk patients. - Monitor renal function: avoid prolonged use in patients with existing kidney disease. - Use caution with concurrent anticoagulants: increased bleeding risk may require closer monitoring. - Avoid in individuals with known hypersensitivity to naproxen or other NSAIDs: discontinue immediately if a reaction occurs. - Limit use during the third trimester of pregnancy: discuss alternatives with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Naproxen can interact with several drug classes; some require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal and renal toxicity. - Lithium: naproxen may increase lithium serum concentrations, risking toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: combined use can impair kidney function. - Corticosteroids: increase the likelihood of gastrointestinal ulceration. - Methotrexate: naproxen can raise methotrexate levels, necessitating dose adjustment. - Selective serotonin reuptake inhibitors (SSRIs): may modestly increase bleeding risk.